X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1301) 1301
Book Review (195) 195
Publication (58) 58
Newsletter (11) 11
Book Chapter (2) 2
Conference Proceeding (1) 1
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lansoprazole (1129) 1129
humans (1097) 1097
index medicus (1089) 1089
male (768) 768
female (718) 718
middle aged (570) 570
proton pump inhibitors (552) 552
omeprazole (548) 548
adult (529) 529
gastroenterology & hepatology (480) 480
2-pyridinylmethylsulfinylbenzimidazoles (442) 442
omeprazole - analogs & derivatives (416) 416
pharmacology & pharmacy (403) 403
aged (391) 391
helicobacter infections - drug therapy (289) 289
treatment outcome (285) 285
anti-ulcer agents - therapeutic use (284) 284
omeprazole - therapeutic use (270) 270
helicobacter pylori (266) 266
omeprazole - adverse effects (265) 265
anti-ulcer agents - adverse effects (233) 233
drug therapy, combination (227) 227
rabeprazole (189) 189
proton pump inhibitor (181) 181
anti-ulcer agents - administration & dosage (177) 177
omeprazole - administration & dosage (172) 172
gastroesophageal reflux - drug therapy (166) 166
pantoprazole (164) 164
double-blind method (161) 161
proton pump inhibitors - adverse effects (161) 161
medicine & public health (160) 160
esomeprazole (157) 157
adolescent (152) 152
proton pump inhibitors - therapeutic use (148) 148
pharmacokinetics (147) 147
prospective studies (146) 146
abridged index medicus (139) 139
infection (134) 134
helicobacter pylori - drug effects (131) 131
aged, 80 and over (128) 128
efficacy (126) 126
amoxicillin - therapeutic use (124) 124
anti-bacterial agents - therapeutic use (123) 123
drug administration schedule (120) 120
proton pump inhibitors - administration & dosage (120) 120
dose-response relationship, drug (119) 119
gastroesophageal reflux (118) 118
gastroesophageal-reflux disease (118) 118
2-pyridinylmethylsulfinylbenzimidazoles - adverse effects (113) 113
clarithromycin (113) 113
drug interactions (113) 113
therapy (112) 112
clarithromycin - therapeutic use (111) 111
amoxicillin (110) 110
2-pyridinylmethylsulfinylbenzimidazoles - therapeutic use (109) 109
eradication (109) 109
double-blind (105) 105
time factors (105) 105
amoxicillin - administration & dosage (104) 104
internal medicine (104) 104
omeprazole - pharmacology (102) 102
ranitidine (102) 102
animals (100) 100
management (99) 99
medicine, general & internal (99) 99
2-pyridinylmethylsulfinylbenzimidazoles - administration & dosage (98) 98
clarithromycin - administration & dosage (98) 98
triple therapy (98) 98
young adult (95) 95
anti-ulcer agents - pharmacology (91) 91
cross-over studies (91) 91
anti-bacterial agents - administration & dosage (89) 89
enzyme inhibitors - adverse effects (86) 86
gastroenterology (85) 85
peptic ulcer - drug therapy (85) 85
drug therapy (83) 83
dosage and administration (79) 79
gastroesophageal reflux disease (79) 79
enzyme inhibitors - therapeutic use (78) 78
proton pump inhibitors - pharmacology (78) 78
risk factors (78) 78
anti-inflammatory agents, non-steroidal - adverse effects (77) 77
anti-bacterial agents - adverse effects (76) 76
safety (76) 76
care and treatment (75) 75
pharmacology/toxicology (75) 75
gastric acid - secretion (74) 74
follow-up studies (72) 72
stomach ulcer - drug therapy (72) 72
metronidazole (71) 71
erosive esophagitis (70) 70
helicobacter-pylori (70) 70
administration, oral (68) 68
research (68) 68
duodenal-ulcer (67) 67
risk (66) 66
amoxicillin - adverse effects (65) 65
oncology (65) 65
child (64) 64
disease (64) 64
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1224) 1224
Japanese (26) 26
French (21) 21
German (19) 19
Spanish (13) 13
Italian (2) 2
Korean (2) 2
Russian (2) 2
Danish (1) 1
Hungarian (1) 1
Norwegian (1) 1
Polish (1) 1
Swedish (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Pediatrics, The, ISSN 0022-3476, 2013, Volume 163, Issue 3, pp. 686 - 691
Objective To determine whether cytochrome P 450CYP 2C19 haplotype associates with lansoprazole-associated adverse event frequency. Study design Respiratory... 
Pediatrics | Sore throat | Poor metabolizer | SNP | Upper respiratory tract infection | Cytochrome P450 | PPI | CYP | Single nucleotide polymorphism | Extensive metabolizer | Wild type | URI | Proton pump inhibitor | COMMUNITY-ACQUIRED PNEUMONIA | METAANALYSIS | PHARMACOKINETICS | GASTROESOPHAGEAL-REFLUX DISEASE | ACID-SUPPRESSIVE DRUGS | PHARMACOGENOMICS | PROTON PUMP INHIBITORS | RISK | PEDIATRICS | BACTERIAL OVERGROWTH | POORLY CONTROLLED ASTHMA | Haplotypes | Bronchitis - genetics | Humans | Aryl Hydrocarbon Hydroxylases - genetics | Male | Genotyping Techniques | Pharyngitis - chemically induced | Respiratory Tract Infections - genetics | Pharyngitis - genetics | 2-Pyridinylmethylsulfinylbenzimidazoles - therapeutic use | Respiratory Tract Infections - chemically induced | Female | Odds Ratio | Child | Bronchitis - chemically induced | Proton Pump Inhibitors - adverse effects | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacokinetics | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Logistic Models | Genetic Markers | Proton Pump Inhibitors - therapeutic use | Asthma - drug therapy | Asthma - genetics | Proton Pump Inhibitors - pharmacokinetics | Cytochrome P-450 CYP2C19 | Adolescent | Polymorphism, Single Nucleotide | Lansoprazole | Complications and side effects | Medical colleges | Pharmacogenetics | Cytochrome P-450 | Drugstores | Genetic aspects | Index Medicus | Abridged Index Medicus
Journal Article
BMC Gastroenterology, ISSN 1471-230X, 03/2013, Volume 13, Issue 1, pp. 56 - 56
Journal Article
Gut, ISSN 0017-5749, 09/2016, Volume 65, Issue 9, pp. 1439 - 1446
ObjectiveThe objective of this study was to assess the efficacy, safety and tolerability of vonoprazan, a novel potassium-competitive acid blocker, as a... 
antibiotic therapy | clinical trials | Helicobacter pylori infection | helicobacter pylori - treatment | CLARITHROMYCIN | LANSOPRAZOLE | MULTICENTER | MANAGEMENT | CLINICAL-TRIAL | PHARMACOKINETICS | JAPAN | INFECTION | MONOFUMARATE TAK-438 | GASTROENTEROLOGY & HEPATOLOGY | AMOXICILLIN | Humans | Middle Aged | Helicobacter Infections - complications | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Pyrroles - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Peptic Ulcer - diagnosis | Pyrroles - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Double-Blind Method | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Sulfonamides - adverse effects | Amoxicillin - adverse effects | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Peptic Ulcer - drug therapy | Breath Tests - methods | Peptic Ulcer - etiology | Sulfonamides - administration & dosage | Usage | Safety and security measures | Research | Helicobacter pylori | Antacids | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | CLINICAL TRIALS | 1506 | ANTIBIOTIC THERAPY | HELICOBACTER PYLORI INFECTION
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 07/2016, Volume 111, Issue 7, pp. 949 - 956
Journal Article
JAMA, ISSN 0098-7484, 05/2011, Volume 305, Issue 19, pp. 1969 - 1977
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 04/2008, Volume 48, Issue 4, pp. 475 - 484
Journal Article
Clinical Pharmacology & Therapeutics, ISSN 0009-9236, 01/2011, Volume 89, Issue 1, pp. 65 - 74
Four randomized, placebo‐controlled, crossover studies were conducted among 282 healthy subjects to investigate whether an interaction exists between... 
VARIABILITY | LANSOPRAZOLE | RABEPRAZOLE | THERAPY | CARDIOVASCULAR EVENTS | STENT PLACEMENT | PHARMACOLOGY & PHARMACY | OUTCOMES | ANTIPLATELET ACTION | PROTON-PUMP INHIBITORS | DRUG-INTERACTION | Proton Pump Inhibitors - pharmacology | Ticlopidine - pharmacology | Humans | Middle Aged | Half-Life | Male | 2-Pyridinylmethylsulfinylbenzimidazoles - pharmacology | Enzyme Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - blood | Young Adult | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Platelet Aggregation Inhibitors - pharmacology | Adult | Female | Omeprazole - pharmacology | Platelet Aggregation - drug effects | Platelet Aggregation Inhibitors - pharmacokinetics | Ticlopidine - pharmacokinetics | Enzyme Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Aryl Hydrocarbon Hydroxylases - antagonists & inhibitors | Double-Blind Method | Drug Administration Schedule | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Enzyme Inhibitors - pharmacology | Omeprazole - adverse effects | Ticlopidine - analogs & derivatives | Cross-Over Studies | Prodrugs - adverse effects | Prodrugs - pharmacokinetics | Cytochrome P-450 CYP2C19 | Platelet Activation - drug effects | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Prodrugs - pharmacology | Ticlopidine - blood | Omeprazole | Pantoprazole | Drug interactions | Analysis | Dosage and administration | Research | Patients | Health aspects | Index Medicus | Abridged Index Medicus
Journal Article
Circulation, ISSN 0009-7322, 08/2013, Volume 128, Issue 8, pp. 845 - 853
BACKGROUND—Proton pump inhibitors (PPIs) are gastric acid–suppressing agents widely prescribed for the treatment of gastroesophageal reflux disease. Recently,... 
dimethylarginine dimethylaminohydrolase | endothelium | proton pump inhibitors | nitric oxide | N,N dimethylarginine | N dimethylarginine | CARDIAC & CARDIOVASCULAR SYSTEMS | EVENTS | ENDOTHELIAL DYSFUNCTION | MYOCARDIAL-INFARCTION | NITRIC-OXIDE SYNTHASE | ACID SUPPRESSION | ADMA | DIMETHYLAMINOHYDROLASE DDAH | PERIPHERAL VASCULAR DISEASE | CORONARY-HEART-DISEASE | STAGE RENAL-DISEASE | ARTERY-DISEASE | Proton Pump Inhibitors - pharmacology | Humans | Esomeprazole - adverse effects | Esomeprazole - pharmacology | Endothelium, Vascular - drug effects | Male | Arginine - analogs & derivatives | Esomeprazole - therapeutic use | Cardiovascular Diseases - epidemiology | Nitric Oxide Synthase Type III - metabolism | Gastroesophageal Reflux - drug therapy | Disease Models, Animal | Amidohydrolases - metabolism | Proton Pump Inhibitors - adverse effects | Cardiovascular Diseases - metabolism | Mice, Inbred C57BL | Risk Factors | Cells, Cultured | Biomarkers - blood | Proton Pump Inhibitors - therapeutic use | Animals | Lansoprazole - adverse effects | Endothelium, Vascular - metabolism | Arginine - blood | Lansoprazole - pharmacology | Endothelium, Vascular - pathology | Mice | Vasodilation - drug effects | Lansoprazole - therapeutic use | Gastroesophageal reflux | Complications and side effects | Usage | Care and treatment | Patient outcomes | Proton pump inhibitors | Cardiovascular diseases | Drug therapy | Health aspects | Risk factors | Index Medicus | Abridged Index Medicus
Journal Article
Gut, ISSN 0017-5749, 11/2016, Volume 65, Issue 11, pp. 1784 - 1792
ObjectiveSignificant heterogeneity was observed in previous trials that assessed the efficacies of sequential therapy for 10 days (S10) versus triple therapy... 
MULTICENTER | METAANALYSIS | MANAGEMENT | EFFICACY | DRUG THERAPY | RESISTANCE | INFECTION | GASTROENTEROLOGY & HEPATOLOGY | Humans | Hospitalization - statistics & numerical data | Helicobacter pylori - drug effects | Male | Drug Monitoring - methods | Proton Pump Inhibitors - administration & dosage | Helicobacter Infections - drug therapy | Clarithromycin - administration & dosage | Metronidazole - adverse effects | Adult | Female | Amoxicillin - administration & dosage | Anti-Bacterial Agents - adverse effects | Helicobacter Infections - diagnosis | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Drug Administration Schedule | Clarithromycin - adverse effects | Metronidazole - administration & dosage | Treatment Outcome | Drug Therapy, Combination - methods | Lansoprazole - adverse effects | Amoxicillin - adverse effects | Ambulatory Care - statistics & numerical data | Helicobacter pylori - isolation & purification | Anti-Bacterial Agents - administration & dosage | Breath Tests - methods | Helicobacter Infections - microbiology | Hospital patients | Care and treatment | Usage | Helicobacter pylori | Therapeutics | Research | Health aspects | Homeopathy | Materia medica and therapeutics | Index Medicus | Abridged Index Medicus | Helicobacter Pylori | HELICOBACTER PYLORI - TREATMENT | 1506 | ANTIBIOTIC THERAPY
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 16, pp. 1756 - 1764
Journal Article
Stroke, ISSN 0039-2499, 03/2015, Volume 46, Issue 3, pp. 722 - 731
BACKGROUND AND PURPOSE—There is controversy and little information about whether individual proton pump inhibitors (PPIs) differentially alter the... 
LANSOPRAZOLE | drug interactions | PROPENSITY SCORE | CARDIOVASCULAR EVENTS | CORONARY | OMEPRAZOLE | stroke | CLINICAL NEUROLOGY | pharmacoepidemiology | proton pump inhibitors | CONCOMITANT USE | platelet aggregation inhibitors | cohort studies | PERIPHERAL VASCULAR DISEASE | HEALTHY-VOLUNTEERS | OUTCOMES | Medicaid | JAPANESE PATIENTS | ARTERY-DISEASE | Rabeprazole - adverse effects | Esomeprazole - administration & dosage | Humans | Middle Aged | Esomeprazole - adverse effects | Male | Risk | Drug Therapy, Combination - adverse effects | Stroke - chemically induced | Proton Pump Inhibitors - administration & dosage | Aged, 80 and over | Ticlopidine - administration & dosage | Female | Stroke - epidemiology | Retrospective Studies | Brain Ischemia - chemically induced | Lansoprazole - administration & dosage | Proton Pump Inhibitors - adverse effects | Data Interpretation, Statistical | Stroke - prevention & control | 2-Pyridinylmethylsulfinylbenzimidazoles - adverse effects | Omeprazole - administration & dosage | Proportional Hazards Models | Omeprazole - adverse effects | Brain Ischemia - prevention & control | Ticlopidine - analogs & derivatives | Lansoprazole - adverse effects | Aged | 2-Pyridinylmethylsulfinylbenzimidazoles - administration & dosage | Rabeprazole - administration & dosage | Index Medicus | Pharmacoepidemiology | Stroke | Drug interactions | Cohort studies | Platelet aggregation inhibitors | Proton pump inhibitors
Journal Article
Journal Article